Peptide and polypeptide inhibitors of complement c1s

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/47 (2006.01) A61K 38/17 (2006.01) C07K 14/435 (2006.01) C07K 14/815 (2006.01) C12P 21/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2413830

The complement system plays an important role in providing resistance to infections and in the pathogenesis of tissue injury. Yet an inappropriate activation of complement can result in a variety of disorders. The present invention provides C1s catalytic site-directed moieties, C1s exosite binding moieties, and bivalent polypeptide inhibitors comprising such moieties, which can be used to treat conditions characterized by inappropriate complement activation.

La présente invention concerne un système qui joue un rôle majeur dans la résistance aux infections et dans la pathogenèse des lésions tissulaires. L'activation appropriée d'un complément peut entraîner divers troubles. La présente invention se rapporte à des fractions catalytiques C1s dirigées sur site, des fractions C1s de liaison à l'exo-site, et des inhibiteurs polypeptidiques bivalents contenant de telles fractions, qui peuvent être utilisés pour traiter des états caractérisés par une activation inappropriée du complément.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide and polypeptide inhibitors of complement c1s does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide and polypeptide inhibitors of complement c1s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide and polypeptide inhibitors of complement c1s will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1707925

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.